Cite
MLA Citation
Christiane Querfeld et al.. “Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study.” Lancet, vol. 8, no. 11, 2021, pp. e808–e817. http://access.bl.uk/ark:/81055/vdc_100145481490.0x000001